+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Malabsorption Syndrome Market by Disease Type (Celiac Disease, Crohn's Disease, Lactose Intolerance), Treatment Type (Dietary Management, Enzyme Supplements, Pharmaceuticals), Distribution Channel, End User, Age Group - Global Forecast 2025-2030- Product Image
Malabsorption Syndrome Market by Disease Type (Celiac Disease, Crohn's Disease, Lactose Intolerance), Treatment Type (Dietary Management, Enzyme Supplements, Pharmaceuticals), Distribution Channel, End User, Age Group - Global Forecast 2025-2030- Product Image
Sale

Malabsorption Syndrome Market by Disease Type (Celiac Disease, Crohn's Disease, Lactose Intolerance), Treatment Type (Dietary Management, Enzyme Supplements, Pharmaceuticals), Distribution Channel, End User, Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674664
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The malabsorption syndrome market is undergoing rapid transformation, propelled by evolving patient needs and new innovations in diagnostics, therapeutics, and digital health. Senior leaders in healthcare and life sciences recognize that optimizing treatment approaches and building resilient supply chains is key to sustained growth in this sector.

Market Snapshot: Malabsorption Syndrome Market Size and Growth

The global malabsorption syndrome market grew from USD 2.49 billion in 2024 to USD 2.63 billion in 2025, and it is forecasted to reach USD 3.45 billion by 2030, reflecting a CAGR of 5.59%. Increasing awareness of gastrointestinal health, coupled with ongoing diagnostic and therapeutic innovations, continues to drive market demand across established and emerging regions.

Scope & Segmentation

This report provides a comprehensive analysis of the malabsorption syndrome market, covering technologies, regions, and patient demographics shaping current and future demand. Segmentation is designed for actionable planning and includes detailed coverage of the following:

  • Disease Types: Celiac disease, Crohn's disease, lactose intolerance, pancreatic insufficiency, short bowel syndrome, and tropical sprue, each requiring specific clinical management strategies.
  • Treatment Types: Dietary management, enzyme supplements including lactase (powder and tablet forms), pancreatic enzymes (microbial and porcine derived), pharmaceuticals such as H2 receptor blockers and proton pump inhibitors (esomeprazole, omeprazole), and probiotics for microbiome support.
  • Distribution Channels: Hospital pharmacies, online pharmacies, and retail channels deliver both acute and chronic therapy solutions.
  • End Users: Clinics, home care settings, hospitals, and research institutes, each with distinct requirements for product delivery, education, and support.
  • Age Groups: Adult, geriatric, and pediatric populations, reflecting diverse prevalence patterns and formulation needs.
  • Regions: Americas (with detail across the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the UK, Germany, France, Saudi Arabia, South Africa, and others), and Asia-Pacific (spanning China, India, Japan, Australia, Southeast Asia, and more).
  • Key Companies: Profiles of leading firms driving innovation and competitive differentiation, including AbbVie Inc., Nestlé S.A., Danone S.A., Reckitt Benckiser Group plc, Baxter International Inc., Abbott Laboratories, Fresenius Kabi AG, Siemens Healthineers AG, Roche Diagnostics International Ltd., and BioMérieux S.A.

Key Takeaways for Market Leaders

  • Demand is rising for advanced diagnostics and patient-centric therapies as awareness of gut health and malabsorptive conditions grows among healthcare professionals and consumers.
  • Non-invasive tools and biomarker-driven approaches accelerate earlier detection, supporting more personalized and effective patient management.
  • Enzyme replacement options and targeted nutrition therapies expand treatment choices, especially for pancreatic insufficiency and lactose intolerance.
  • The convergence of digital health platforms with clinical protocols enables data-driven monitoring, remote symptom tracking, and optimized adherence—key advantages for payer-provider networks.
  • Strategic collaborations between industry leaders, biotech firms, and research institutes are mitigating operational risks and fast-tracking the development of niche and biosimilar products.
  • Understanding patient subgroup differences by age, disease etiology, and care setting is essential for tailoring products and services to maximize outcomes and market uptake.

Tariff Impact: Navigating 2025 US Trade Policy

Forthcoming tariffs in the United States will affect costs and sourcing strategies for enzyme ingredients and active pharmaceutical components across the malabsorption syndrome treatment supply chain. Stakeholders are reassessing procurement approaches, increasing localization, and collaborating with domestic suppliers to preserve cost competitiveness while ensuring continuity of care. Shifts in payer reimbursement and insurance coverage are anticipated, with emphasis on adopting generics or value-based alternatives.

Research Methodology & Data Sources

This analysis integrates quantitative data from advanced statistical modeling with qualitative insights from interviews with key opinion leaders, clinicians, procurement professionals, and supply chain executives. Secondary research draws on peer-reviewed literature, regulatory filings, and clinical trial databases. Findings have been externally reviewed to validate accuracy and relevance.

Why This Report Matters

  • Inform high-value decision making with actionable segmentation and geographic insights to align growth strategies with evolving market realities.
  • Anticipate regulatory and supply chain shifts by leveraging comprehensive intelligence on upcoming tariffs and operational resilience measures.
  • Benchmark your organization’s approach against innovation leaders and emerging disruptors to identify immediate and long-term opportunities for expansion.

Conclusion

A dynamic malabsorption syndrome market landscape demands agile strategies, informed decision making, and targeted investment in clinical and digital solutions. This report equips leaders to navigate complexity, optimize resources, and unlock both patient and organizational value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for targeted enzyme replacement therapies for pancreatic insufficient malabsorption
5.2. Expansion of fecal microbiota transplantation research for small intestine bacterial overgrowth management
5.3. Growing investments in next-generation probiotic formulations to enhance nutrient absorption in celiac patients
5.4. Surge in clinical trials evaluating novel oral bile acid sequestrants for cholestatic malabsorption
5.5. Adoption of digital health platforms for remote monitoring of malabsorption syndrome therapy adherence
5.6. Development of precision nutrition algorithms integrating genomic and microbiome data for malabsorption management
5.7. Emergence of long-acting recombinant pancreatic enzymes with enhanced gastroresistance and bioavailability
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Malabsorption Syndrome Market, by Disease Type
8.1. Introduction
8.2. Celiac Disease
8.3. Crohn's Disease
8.4. Lactose Intolerance
8.5. Pancreatic Insufficiency
8.6. Short Bowel Syndrome
8.7. Tropical Sprue
9. Malabsorption Syndrome Market, by Treatment Type
9.1. Introduction
9.2. Dietary Management
9.3. Enzyme Supplements
9.3.1. Lactase Enzymes
9.3.1.1. Powder Form
9.3.1.2. Tablet Form
9.3.2. Pancreatic Enzymes
9.3.2.1. Microbial Derived
9.3.2.2. Porcine Derived
9.4. Pharmaceuticals
9.4.1. H2 Receptor Blockers
9.4.2. Proton Pump Inhibitors
9.4.2.1. Esomeprazole
9.4.2.2. Omeprazole
9.5. Probiotics
10. Malabsorption Syndrome Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Malabsorption Syndrome Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care Settings
11.4. Hospitals
11.5. Research Institutes
12. Malabsorption Syndrome Market, by Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Americas Malabsorption Syndrome Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Malabsorption Syndrome Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Malabsorption Syndrome Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Nestlé S.A.
16.3.3. Danone S.A.
16.3.4. Reckitt Benckiser Group plc
16.3.5. Baxter International Inc.
16.3.6. Abbott Laboratories
16.3.7. Fresenius Kabi AG
16.3.8. Siemens Healthineers AG
16.3.9. Roche Diagnostics International Ltd.
16.3.10. BioMérieux S.A.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MALABSORPTION SYNDROME MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MALABSORPTION SYNDROME MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MALABSORPTION SYNDROME MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MALABSORPTION SYNDROME MARKET: RESEARCHAI
FIGURE 26. MALABSORPTION SYNDROME MARKET: RESEARCHSTATISTICS
FIGURE 27. MALABSORPTION SYNDROME MARKET: RESEARCHCONTACTS
FIGURE 28. MALABSORPTION SYNDROME MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MALABSORPTION SYNDROME MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY CELIAC DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY CELIAC DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY LACTOSE INTOLERANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY LACTOSE INTOLERANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC INSUFFICIENCY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC INSUFFICIENCY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY SHORT BOWEL SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY SHORT BOWEL SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY TROPICAL SPRUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY TROPICAL SPRUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY DIETARY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY DIETARY MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY POWDER FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY POWDER FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY TABLET FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY TABLET FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY MICROBIAL DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY MICROBIAL DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PORCINE DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PORCINE DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY H2 RECEPTOR BLOCKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY H2 RECEPTOR BLOCKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY ESOMEPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY ESOMEPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY OMEPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY OMEPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MALABSORPTION SYNDROME MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES MALABSORPTION SYNDROME MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 133. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 138. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 139. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 140. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2025-2030 (USD MILLION)
TABLE 141. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2018-2024 (USD MILLION)
TABLE 142. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2025-2030 (USD MILLION)
TABLE 143. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 144. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 145. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 146. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 147. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 152. CANADA MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 153. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 160. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2025-2030 (USD MILLION)
TABLE 161. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2018-2024 (USD MILLION)
TABLE 162. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2025-2030 (USD MILLION)
TABLE 163. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 166. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 167. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 172. MEXICO MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA MALABSORPTION SYNDROME MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 255. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 256. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 257. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 258. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 259. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 262. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2025-2030 (USD MILLION)
TABLE 263. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2018-2024 (USD MILLION)
TABLE 264. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2025-2030 (USD MILLION)
TABLE 265. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 267. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 268. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 269. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 274. GERMANY MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 275. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 276. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 277. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 278. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 279. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 282. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2025-2030 (USD MILLION)
TABLE 283. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2018-2024 (USD MILLION)
TABLE 284. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2025-2030 (USD MILLION)
TABLE 285. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 286. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 287. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 288. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 289. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 294. FRANCE MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY PANCREATIC ENZYMES, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA MALABSORPTION SYNDROME MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 315. ITALY MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 316. ITALY MALABSORPTION SYNDROME MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 317. ITALY MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 318. ITALY MALABSORPTION SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 319. ITALY MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 320. ITALY MALABSORPTION SYNDROME MARKET SIZE, BY ENZYME SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 321. ITALY MALABSORPTION SYNDROME MARKET SIZE, BY LACTASE ENZYMES, 2018-2024 (USD MILLION)
TABLE 322. ITALY MALABSO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Malabsorption Syndrome market report include:
  • AbbVie Inc.
  • Nestlé S.A.
  • Danone S.A.
  • Reckitt Benckiser Group plc
  • Baxter International Inc.
  • Abbott Laboratories
  • Fresenius Kabi AG
  • Siemens Healthineers AG
  • Roche Diagnostics International Ltd.
  • BioMérieux S.A.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.63 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.45 Billion
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Short Bowel Syndrome - Epidemiology Forecast - 2034 - Product Image

Short Bowel Syndrome - Epidemiology Forecast - 2034

  • Report
  • 66 Pages
  • Global
From
Celiac Disease Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Celiac Disease Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 130 Pages
  • Global
From
Short Bowel Syndrome (SBS) - Global Strategic Business Report - Product Image

Short Bowel Syndrome (SBS) - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Short Bowel Syndrome Market by Treatment Type (Oral Supplementation, Parenteral Nutrition, Pharmacological Therapy), Product Type (Adjunctive Therapies, Enteral Formulas, Pharmacologics), Route Of Administration, End Use, Patient Age, Etiology - Global Forecast 2025-2030 - Product Image

Short Bowel Syndrome Market by Treatment Type (Oral Supplementation, Parenteral Nutrition, Pharmacological Therapy), Product Type (Adjunctive Therapies, Enteral Formulas, Pharmacologics), Route Of Administration, End Use, Patient Age, Etiology - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Dyspepsia Drugs - Global Strategic Business Report - Product Image

Dyspepsia Drugs - Global Strategic Business Report

  • Report
  • 566 Pages
  • Global
From

About the Malabsorption Syndrome Drug Market

Malabsorption Syndrome Drugs are a type of Gastrointestinal Drugs used to treat malabsorption syndrome, a condition in which the body is unable to absorb nutrients from food. These drugs are used to replace the missing nutrients and help the body absorb them. Commonly used drugs include pancreatic enzymes, bile acid sequestrants, and probiotics. Pancreatic enzymes are used to replace the enzymes that the pancreas is unable to produce, while bile acid sequestrants are used to bind bile acids and prevent them from being reabsorbed. Probiotics are used to restore the balance of beneficial bacteria in the gut. Some companies in the Malabsorption Syndrome Drug market include AbbVie, Allergan, AstraZeneca, Bayer, GlaxoSmithKline, Merck, Novartis, Pfizer, and Takeda. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.